Does gabapentin cause dementia
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Its Association with Dementia
Gabapentin and Increased Risk of Dementia
Population-Based Studies on Gabapentin and Dementia Risk
Recent research has indicated a potential link between gabapentin use and an increased risk of dementia. A comprehensive study utilizing data from the National Health Insurance Research Database in Taiwan found that patients treated with gabapentin or pregabalin had a significantly higher incidence of dementia compared to non-users. Specifically, the study reported a multivariate-adjusted hazard ratio of 1.45, indicating a 45% increased risk of dementia among gabapentin users . This risk was notably higher in younger patients under the age of 50 .
Neurocognitive Changes in Older Adults
Further supporting these findings, another study focused on older adults with normal cognition at baseline found that gabapentin initiation was associated with significant neurocognitive declines. This included worsening scores on the Clinical Dementia Rating and increased functional status decline, as well as a higher incidence of falls . These results suggest that gabapentin may contribute to cognitive and functional deterioration in older adults.
Gabapentin in the Treatment of Dementia Symptoms
Behavioral and Psychological Symptoms of Dementia (BPSD)
Despite the potential risks, gabapentin has been explored as a treatment for behavioral and psychological symptoms of dementia (BPSD). Several case reports and small-scale studies have suggested that gabapentin can be effective in managing symptoms such as aggression and agitation in dementia patients 456. For instance, a retrospective chart review found that gabapentin improved aggressive and agitated behaviors in a majority of patients with dementia, with minimal side effects .
Mixed Results in Clinical Efficacy
However, the efficacy of gabapentin in treating BPSD is not universally supported. Some studies have reported mixed results, with a significant portion of patients showing no improvement or experiencing adverse effects such as sedation and gait instability 78. These findings highlight the need for more rigorous, controlled studies to better understand the benefits and risks of gabapentin in this context.
Gabapentin and Vascular Dementia
Combination Therapies
In animal models, gabapentin combined with Dioscorea opposita Thunb extracts has shown promise in improving cognitive function and reducing neuronal damage in vascular dementia . This combination therapy was found to modulate P2X7 receptor expression, which may play a role in its neuroprotective effects . While these results are promising, they are preliminary and require further validation in human studies.
Conclusion
The current body of research suggests a complex relationship between gabapentin use and dementia. While there is evidence indicating an increased risk of dementia with gabapentin use, particularly in younger and older adults, there are also studies suggesting its potential utility in managing BPSD. Given these conflicting findings, it is crucial for healthcare providers to weigh the risks and benefits of gabapentin on a case-by-case basis and to consider alternative treatments where appropriate. Further research is needed to clarify the long-term cognitive effects of gabapentin and to establish clear guidelines for its use in dementia patients.
Sources and full results
Most relevant research papers on this topic